ATE268768T1 - Antithrombosemittel - Google Patents

Antithrombosemittel

Info

Publication number
ATE268768T1
ATE268768T1 AT98920095T AT98920095T ATE268768T1 AT E268768 T1 ATE268768 T1 AT E268768T1 AT 98920095 T AT98920095 T AT 98920095T AT 98920095 T AT98920095 T AT 98920095T AT E268768 T1 ATE268768 T1 AT E268768T1
Authority
AT
Austria
Prior art keywords
formula
antithrombotic agents
novel compounds
compounds
intermediates
Prior art date
Application number
AT98920095T
Other languages
English (en)
Inventor
Nickolay Yuri Chirgadze
Matthew Joseph Fisher
Richard Waltz Harper
Ho-Shen Lin
Jefferson Ray Mccowan
Alan David Palkowitz
Michael Enrico Richett
Daniel Jon Sall
Gerald Floyd Smith
Kumiko Takeuchi
Minsheng Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE268768T1 publication Critical patent/ATE268768T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98920095T 1997-04-30 1998-04-30 Antithrombosemittel ATE268768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4429697P 1997-04-30 1997-04-30
PCT/US1998/008831 WO1998049160A1 (en) 1997-04-30 1998-04-30 Antithrombotic agents

Publications (1)

Publication Number Publication Date
ATE268768T1 true ATE268768T1 (de) 2004-06-15

Family

ID=21931578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920095T ATE268768T1 (de) 1997-04-30 1998-04-30 Antithrombosemittel

Country Status (9)

Country Link
US (1) US6271227B1 (de)
EP (1) EP0980366B1 (de)
JP (1) JP2001522373A (de)
AT (1) ATE268768T1 (de)
AU (1) AU7274198A (de)
CA (1) CA2287982A1 (de)
DE (1) DE69824410T2 (de)
ES (1) ES2223129T3 (de)
WO (1) WO1998049160A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2306489A1 (en) * 1997-10-03 1999-04-15 Mark Gregory Stocksdale Benzothiophenes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
US3293263A (en) 1963-12-09 1966-12-20 Upjohn Co Diphenylbenzocycloalkenes
GB1456323A (en) 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4001426A (en) 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3157882B2 (ja) 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
AU1440395A (en) 1993-12-21 1995-07-10 Eli Lilly And Company Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
EP0736007A4 (de) 1993-12-21 1997-03-19 Lilly Co Eli Nicht-peptidische tachykinin rezeptor antagonisten
US5441965A (en) 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
IL115582A0 (en) 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
US5510357A (en) 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US5523309A (en) 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
US5567828A (en) 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
US5532254A (en) 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
JP2002500618A (ja) * 1995-10-31 2002-01-08 イーライ・リリー・アンド・カンパニー 抗血栓性ジアミン

Also Published As

Publication number Publication date
DE69824410T2 (de) 2005-06-02
JP2001522373A (ja) 2001-11-13
ES2223129T3 (es) 2005-02-16
EP0980366A1 (de) 2000-02-23
CA2287982A1 (en) 1998-11-05
WO1998049160A1 (en) 1998-11-05
AU7274198A (en) 1998-11-24
EP0980366B1 (de) 2004-06-09
US6271227B1 (en) 2001-08-07
DE69824410D1 (en) 2004-07-15
EP0980366A4 (de) 2000-05-17

Similar Documents

Publication Publication Date Title
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
SE9504661D0 (sv) New compounds
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE69634045D1 (de) Antithrombotische diamine
DE69931393D1 (de) Antithrombotische amide
DE69919212D1 (de) Aromatische amiden
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
SE8804629D0 (sv) New therapeutically active compounds
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
SE0100569D0 (sv) New compounds
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
SE0102055D0 (sv) New Compounds
DE69819539D1 (de) Antithrombotische mittel
SE9804212D0 (sv) Compounds
SE9801494D0 (sv) Novel use
ATE308540T1 (de) Antithrombosemittel
EP1027051A4 (de) Antithrombotische mittel
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
SE9504662D0 (sv) New compounds
ATE268768T1 (de) Antithrombosemittel
TR199900013T2 (xx) Yeni bile�ikler.
AU1434201A (en) Antithrombotic agents
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties